Stay updated on Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial

Sign up to get notified when there's something new on the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.4.3 instead of Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T23:49:36.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The Blood 2024 publication citation Friedberg et al. was added and subsequently removed from the Publications section.
    Difference
    0.0%
    Check dated 2026-03-04T23:51:58.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.4.2, replacing the previous Revision: v3.4.1. The notice about lapse in government funding was removed.
    Difference
    0.3%
    Check dated 2026-02-11T14:26:06.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and updated the publications section with a 2024 Blood article citation; the page revision was updated to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T10:28:49.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Adds a glossary display option and updates QC metadata to Revision: v3.4.0, while removing older QC wording. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T06:22:23.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision tag updated from v3.3.3 to v3.3.4.
    Difference
    0.0%
    Check dated 2026-01-14T02:46:35.000Z thumbnail image

Stay in the know with updates to Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page.